Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase

Lesley G. Ellies, Michael Fishman, Joy Hardison, Jeanine Kleeman, Jeannie E. Maglione, Cathyryne K. Manner, Robert Cardiff, Carol L. MacLeod

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Nitric oxide (NO) and its metabolites are implicated in carcinogenesis and metastasis. Both stimulatory and inhibitory effects of NO have been reported in relation to breast cancer and its role in the development of malignancies and metastasis remains uncertain. We have used the polyomavirus middle T antigen (PyV-mT) targeted to the mouse mammary gland and bred into an inducible NO synthase (iNOS)-deficient C57B1/6 strain to examine a role for nitric oxide in modulating tumors that develop in the complex environment of the whole animal. The development of hyperplasias was delayed to the extent that the earliest palpable tumors arose 2-4 weeks later in PyV-mT/iNOS-/- mice compared with PyV-mT/iNOS+/+ mice, identifying a role for iNOS in early events in mammary tumor formation. Tumors that did develop in PyV-mT/iNOS-/- mice were characteristically well differentiated and had a cribriform pattern. Other tumors were myoepithelial adenocarcinomas with uniform nuclear size. In contrast, mice capable of iNOS activity typically developed solid nodular adenocarcinomas with a high mitotic index and pleomorphic nuclei. No significant effect of iNOS deficiency was found on vascular density in hyperplasias or tumors by examining CD31-positive vessels. The infiltration of lesions by macrophages, cells capable of significant NO production, remained unchanged in PyV-mT/iNOS-/- mice. Metastatic potential was retained by PyV-mT-transformed epithelium in the absence of iNOS, indicating that NO production by iNOS is not essential for this process. These results indicate a role for iNOS in tumorigenesis, particularly in the regulation of early events.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalInternational Journal of Cancer
Volume106
Issue number1
DOIs
StatePublished - Aug 10 2003

Fingerprint

Nitric Oxide Synthase Type II
Nitric Oxide Synthase
Polyomavirus Transforming Antigens
Breast Neoplasms
Nitric Oxide
Neoplasms
Hyperplasia
Carcinogenesis
Adenocarcinoma
Myoepithelioma
Neoplasm Metastasis
Mitotic Index
Human Mammary Glands
Blood Vessels
Epithelium
Macrophages

Keywords

  • Breast
  • Cancer
  • iNOS
  • Mouse
  • Polyomavirus middle T antigen

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Ellies, L. G., Fishman, M., Hardison, J., Kleeman, J., Maglione, J. E., Manner, C. K., ... MacLeod, C. L. (2003). Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase. International Journal of Cancer, 106(1), 1-7. https://doi.org/10.1002/ijc.11178

Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase. / Ellies, Lesley G.; Fishman, Michael; Hardison, Joy; Kleeman, Jeanine; Maglione, Jeannie E.; Manner, Cathyryne K.; Cardiff, Robert; MacLeod, Carol L.

In: International Journal of Cancer, Vol. 106, No. 1, 10.08.2003, p. 1-7.

Research output: Contribution to journalArticle

Ellies, LG, Fishman, M, Hardison, J, Kleeman, J, Maglione, JE, Manner, CK, Cardiff, R & MacLeod, CL 2003, 'Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase', International Journal of Cancer, vol. 106, no. 1, pp. 1-7. https://doi.org/10.1002/ijc.11178
Ellies LG, Fishman M, Hardison J, Kleeman J, Maglione JE, Manner CK et al. Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase. International Journal of Cancer. 2003 Aug 10;106(1):1-7. https://doi.org/10.1002/ijc.11178
Ellies, Lesley G. ; Fishman, Michael ; Hardison, Joy ; Kleeman, Jeanine ; Maglione, Jeannie E. ; Manner, Cathyryne K. ; Cardiff, Robert ; MacLeod, Carol L. / Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase. In: International Journal of Cancer. 2003 ; Vol. 106, No. 1. pp. 1-7.
@article{ad424b152ead4573aa0de69bda858e8c,
title = "Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase",
abstract = "Nitric oxide (NO) and its metabolites are implicated in carcinogenesis and metastasis. Both stimulatory and inhibitory effects of NO have been reported in relation to breast cancer and its role in the development of malignancies and metastasis remains uncertain. We have used the polyomavirus middle T antigen (PyV-mT) targeted to the mouse mammary gland and bred into an inducible NO synthase (iNOS)-deficient C57B1/6 strain to examine a role for nitric oxide in modulating tumors that develop in the complex environment of the whole animal. The development of hyperplasias was delayed to the extent that the earliest palpable tumors arose 2-4 weeks later in PyV-mT/iNOS-/- mice compared with PyV-mT/iNOS+/+ mice, identifying a role for iNOS in early events in mammary tumor formation. Tumors that did develop in PyV-mT/iNOS-/- mice were characteristically well differentiated and had a cribriform pattern. Other tumors were myoepithelial adenocarcinomas with uniform nuclear size. In contrast, mice capable of iNOS activity typically developed solid nodular adenocarcinomas with a high mitotic index and pleomorphic nuclei. No significant effect of iNOS deficiency was found on vascular density in hyperplasias or tumors by examining CD31-positive vessels. The infiltration of lesions by macrophages, cells capable of significant NO production, remained unchanged in PyV-mT/iNOS-/- mice. Metastatic potential was retained by PyV-mT-transformed epithelium in the absence of iNOS, indicating that NO production by iNOS is not essential for this process. These results indicate a role for iNOS in tumorigenesis, particularly in the regulation of early events.",
keywords = "Breast, Cancer, iNOS, Mouse, Polyomavirus middle T antigen",
author = "Ellies, {Lesley G.} and Michael Fishman and Joy Hardison and Jeanine Kleeman and Maglione, {Jeannie E.} and Manner, {Cathyryne K.} and Robert Cardiff and MacLeod, {Carol L.}",
year = "2003",
month = "8",
day = "10",
doi = "10.1002/ijc.11178",
language = "English (US)",
volume = "106",
pages = "1--7",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase

AU - Ellies, Lesley G.

AU - Fishman, Michael

AU - Hardison, Joy

AU - Kleeman, Jeanine

AU - Maglione, Jeannie E.

AU - Manner, Cathyryne K.

AU - Cardiff, Robert

AU - MacLeod, Carol L.

PY - 2003/8/10

Y1 - 2003/8/10

N2 - Nitric oxide (NO) and its metabolites are implicated in carcinogenesis and metastasis. Both stimulatory and inhibitory effects of NO have been reported in relation to breast cancer and its role in the development of malignancies and metastasis remains uncertain. We have used the polyomavirus middle T antigen (PyV-mT) targeted to the mouse mammary gland and bred into an inducible NO synthase (iNOS)-deficient C57B1/6 strain to examine a role for nitric oxide in modulating tumors that develop in the complex environment of the whole animal. The development of hyperplasias was delayed to the extent that the earliest palpable tumors arose 2-4 weeks later in PyV-mT/iNOS-/- mice compared with PyV-mT/iNOS+/+ mice, identifying a role for iNOS in early events in mammary tumor formation. Tumors that did develop in PyV-mT/iNOS-/- mice were characteristically well differentiated and had a cribriform pattern. Other tumors were myoepithelial adenocarcinomas with uniform nuclear size. In contrast, mice capable of iNOS activity typically developed solid nodular adenocarcinomas with a high mitotic index and pleomorphic nuclei. No significant effect of iNOS deficiency was found on vascular density in hyperplasias or tumors by examining CD31-positive vessels. The infiltration of lesions by macrophages, cells capable of significant NO production, remained unchanged in PyV-mT/iNOS-/- mice. Metastatic potential was retained by PyV-mT-transformed epithelium in the absence of iNOS, indicating that NO production by iNOS is not essential for this process. These results indicate a role for iNOS in tumorigenesis, particularly in the regulation of early events.

AB - Nitric oxide (NO) and its metabolites are implicated in carcinogenesis and metastasis. Both stimulatory and inhibitory effects of NO have been reported in relation to breast cancer and its role in the development of malignancies and metastasis remains uncertain. We have used the polyomavirus middle T antigen (PyV-mT) targeted to the mouse mammary gland and bred into an inducible NO synthase (iNOS)-deficient C57B1/6 strain to examine a role for nitric oxide in modulating tumors that develop in the complex environment of the whole animal. The development of hyperplasias was delayed to the extent that the earliest palpable tumors arose 2-4 weeks later in PyV-mT/iNOS-/- mice compared with PyV-mT/iNOS+/+ mice, identifying a role for iNOS in early events in mammary tumor formation. Tumors that did develop in PyV-mT/iNOS-/- mice were characteristically well differentiated and had a cribriform pattern. Other tumors were myoepithelial adenocarcinomas with uniform nuclear size. In contrast, mice capable of iNOS activity typically developed solid nodular adenocarcinomas with a high mitotic index and pleomorphic nuclei. No significant effect of iNOS deficiency was found on vascular density in hyperplasias or tumors by examining CD31-positive vessels. The infiltration of lesions by macrophages, cells capable of significant NO production, remained unchanged in PyV-mT/iNOS-/- mice. Metastatic potential was retained by PyV-mT-transformed epithelium in the absence of iNOS, indicating that NO production by iNOS is not essential for this process. These results indicate a role for iNOS in tumorigenesis, particularly in the regulation of early events.

KW - Breast

KW - Cancer

KW - iNOS

KW - Mouse

KW - Polyomavirus middle T antigen

UR - http://www.scopus.com/inward/record.url?scp=0038207007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038207007&partnerID=8YFLogxK

U2 - 10.1002/ijc.11178

DO - 10.1002/ijc.11178

M3 - Article

C2 - 12794750

AN - SCOPUS:0038207007

VL - 106

SP - 1

EP - 7

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -